Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
AssigneeGenkyotex SA
InventorsPatrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Life of this patent
Estimating the term…
Abstract
The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Claims23
A method for the inhibiting, arresting the development of, relieving the symptoms of and/or causing regression of the symptoms of a patient suffering from cardiovascular disorders, respiratory disorders, metabolism disorders, skin disorders, bone disorders, neuroinflammatory and/or neurodegenerative disorders, kidney diseases, reproduction disorders, diseases affecting the eye and/or the lens and/or conditions affecting the inner ear, inflammatory disorders, liver diseases, pain, cancers, allergic disorders, traumatisms, septic, hemorrhagic and anaphylactic shock, disorders of the gastrointestinal system, angiogenesis and angiogenesis-dependent conditions, the method comprising administering a pyrazolo pyridine derivative according to Formula (I):
- wherein G1 is selected from H;
- optionally substituted acyl;
- optionally substituted acyl C1-C6 alkyl;
- optionally substituted alkyl C3-C8-cycloalkyl alkyl;
- optionally substituted heterocycloalkyl alkyl;
- optionally substituted aryl alkyl;
- and optionally substituted heteroaryl alkyl;
- G2 is selected from —CHR1R2 and a saturated ring system selected from optionally substituted C3-C8-cycloalkyl and optionally substituted heterocycloalkyl;
- R1 and R2 are independently selected from H;
- optionally substituted alkoxy;
- optionally substituted alkoxy C1-C6 alkyl;
- optionally substituted amino;
- optionally substituted aminoalkyl;
- optionally substituted acyl;
- C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted C1-C6 alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted C1-C6 alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- or —CHR1R2 form together a ring selected from optionally substituted C3-C8-cycloalkyl and optionally substituted heterocycloalkyl;
- G3 is selected from H;
- optionally substituted amino;
- optionally substituted aminoalkyl;
- optionally substituted aminocarbonyl;
- optionally substituted alkoxy;
- optionally substituted alkoxy C1-C6 alkyl;
- optionally substituted carbonyl;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted C1-C6 alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted C1-C6 alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- G4 is selected from H;
- optionally substituted acyl;
- optionally substituted acyl amino;
- optionally substituted acyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted C1-C6 alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted C1-C6 alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- G5 is selected from H;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted C1-C6 alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted C1-C6 alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- or a tautomer, geometrical isomer, optically active form as enantiomer, diastereomer and racemate forms or a pharmaceutically acceptable salt thereof, to a patient in need of treatment of said disease or condition.
A method for inhibiting angiogenesis in a patient suffering from angiogenesis or angiogenesis dependent disorder, wherein the method comprises administering an angiogenesis inhibitory dose of a compound of Formula (I)
- wherein G1 is selected from H;
- optionally substituted acyl;
- optionally substituted acyl C1-C6 alkyl;
- optionally substituted alkyl;
- optionally substituted C3-C8-cycloalkyl alkyl;
- optionally substituted heterocycloalkyl alkyl;
- optionally substituted aryl alkyl;
- and heteroaryl alkyl;
- G2 is selected from H;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- heterocycloalkyl;
- optionally substituted alkyl C3-C8-cycloalkyl;
- C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- G3 is selected from —(CH2)n—R1 and —(CH2)p—R5;
- R1 is selected from —NR2R3;
- —OR4;
- optionally substituted heterocycloalkyl;
- optionally substituted heteroaryl;
- —CHR6R7;
- optionally substituted acyl and —C(O)NR2R3;
- R2 and R3 are independently selected from H;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl or NR2R3 form a ring selected from optionally substituted heteroaryl and optionally substituted heterocycloalkyl;
- R4 is selected from H;
- optionally substituted alkoxy C1-C6 alkyl;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- R5 is selected from H;
- optionally substituted alkoxy;
- optionally substituted alkoxy C1-C6 alkyl;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- R6 and R7 are independently selected from optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl or —CHR6R7 forms an optionally substituted ring selected from optionally substituted heteroaryl, optionally substituted cycloalkyl and optionally substituted heterocycloalkyl;
- n is an integer selected from 0 to 5;
- p is an integer selected from 3 to 5;
- G4 is selected from H;
- optionally substituted acyl;
- acyl amino;
- optionally substituted acyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- heteroaryl;
- optionally substituted C1-C6 alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted C1-C6 alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- G5 is selected from H;
- optionally substituted C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl;
- optionally substituted C2-C6 alkynyl;
- optionally substituted aryl;
- optionally substituted C1-C6 alkyl aryl;
- optionally substituted aryl C1-C6 alkyl;
- optionally substituted heteroaryl;
- optionally substituted C1-C6 alkyl heteroaryl;
- optionally substituted heteroaryl C1-C6 alkyl;
- optionally substituted C2-C6 alkenyl aryl;
- optionally substituted aryl C2-C6 alkenyl;
- optionally substituted C2-C6 alkenyl heteroaryl;
- optionally substituted heteroaryl C2-C6 alkenyl;
- optionally substituted C3-C8-cycloalkyl;
- optionally substituted heterocycloalkyl;
- optionally substituted C1-C6 alkyl C3-C8-cycloalkyl;
- optionally substituted C3-C8-cycloalkyl C1-C6 alkyl;
- optionally substituted C1-C6 alkyl heterocycloalkyl and optionally substituted heterocycloalkyl C1-C6 alkyl;
- or a tautomer, geometrical isomer, optically active form as enantiomer, diastereomer and racemate forms or a pharmaceutically acceptable salt thereof, in a patient in need thereof.
Dependencies are inferred from the claim text.